Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Pfizer 15.034, Structure Therapeutics 0.
Pfizer vs Structure Therapeutics: Revenue Comparison
Pfizer (PFE) and Structure Therapeutics (GPCR) are peers in GLP-1. Pfizer reported revenue of $15.0B as of Q2 2026, compared with $0 for Structure Therapeutics. Pfizer leads on revenue.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Pfizer, Structure Therapeutics.| Metric | Pfizer | Structure Therapeutics |
|---|---|---|
| Market Cap | - | - |
| Revenue | $15.03B | $0 |
| Cost of Revenue | $4.09B | $0 |
| Gross Profit | $10.94B | $0 |
| Operating Income | $4.71B | $-119.00M |
| Net Income | $-246.00M | $-106.00M |
| R&D Expense | $2.81B | $100.00M |
| Earnings Per Share | -$0.04 | -$1.47 |
| Gross Margin | 72.8% | - |
| Operating Margin | 31.3% | - |
| Net Profit Margin | -1.6% | - |
| Free Cash Flow | $302.00M | $-120.00M |
| Cumulative Free Cash Flow | $356.70B | $-589.00M |
| Operating Cash Flow | $835.00M | $-120.00M |
| Cash & Equivalents | $976.00M | $273.00M |